Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Alister J Bates Improving Outcomes in Pediatric Obstructive Sleep Apnea with Computational Fluid Dynamics National Institutes of Health (NIH) K99HL144822 09/01/2019 - 08/31/2020 $153,171
Anil Goud Jegga DVM
Anjaparavanda Naren, PHD
John Paul Clancy, MD		 Preclinical characterization of saracatinib for cystic fibrosis therapy National Institutes of Health (NIH) UG3 TR002612 09/01/2019 - 08/31/2020 $212,000
Anjaparavanda Naren, PHD Personalizing Cystic Fibrosis Research Translation Cystic Fibrosis Foundation Naren19R0 07/01/2019 - 06/30/2020 $600,000
Anjaparavanda Naren, PHD LPA2 receptor-containing complexes in regulating secreto National Institutes of Health (NIH) R01DK093045 07/01/2019 - 06/30/2020 $351,000
Anjaparavanda Naren, PHD Transporters and hematopoietic toxicity St Jude's Children's Hospital (National Institutes of Health) R01CA194206 07/01/2019 - 06/30/2020 $28,595
Anjaparavanda Naren, PHD
John Paul Clancy, MD
Jeffrey A Whitsett, MD		 Personalized Cystic Fibrosis Therapy and Research Center National Institutes of Health (NIH) P30DK117467 07/01/2019 - 06/30/2020 $775,380.67
Assem Ziady, PHD Longitudinal Study of Cystic Fibrosis Liver Disease University of Colorado (Cystic Fibrosis Foundation ) NARKEW16AB0 01/01/2019 - 12/31/2019 $10,342
Barbara A Chini, MD First and Second year Clinical Fellowship Cystic Fibrosis Foundation 0001077 07/01/2019 - 06/30/2020 $66,750
Christopher Siracusa, MD Design CF: Developing e-Health Systems to Improve Growth and Nutrition in CF (Phase II) Children's Hospital Boston (Cystic Fibrosis Foundation ) CHB;Siracusa 06/01/2018 - 12/31/2019 $124,271
Christopher Siracusa, MD Success with Therapies Research Consortium Cystic Fibrosis Foundation SIRACU15PE0 08/01/2019 - 07/31/2020 $32,400
Christopher Siracusa, MD Reducing Stress & Incorporating Wellness Around New Diagnosis in CF Cystic Fibrosis Foundation SIRACU18QI0 08/01/2019 - 07/31/2020 $43,200
Duncan E Keegan, MD First and Second Year Clinical Fellowship Cystic Fibrosis Foundation KEEGAN19B0 07/01/2019 - 06/30/2020 $61,750
Elizabeth L Kramer, MD-PHD The Role of TGF in Driving Airway Hyperresponsiveness and Smooth Muscle Dysfunction in Cystic Fibrosis Cystic Fibrosis Research, Inc. Cystic Fib - Kramer, 06/01/2019 - 05/31/2020 $70,000
Gary McPhail, MD Cystic Fibrosis Center Program Accreditation And Funding Cystic Fibrosis Foundation CC160-130 07/01/2019 - 06/30/2020 $167,845
Gary McPhail, MD Improving P. aeruginosa detection in non-expectorators via breath testing Dartmouth College (Cystic Fibrosis Foundation ) R1021 04/01/2019 - 03/31/2020 $16,164
Gary McPhail, MD Improving outcomes in CF patients: Toward rapid detection of P. aeruginosa Dartmouth College (National Institutes of Health) R1069 09/01/2019 - 08/31/2020 $25,027
Jason C Woods, PHD Hyperpolarized Imaging for New Therapies (HyPOINT) in Pediatric CF Cystic Fibrosis Foundation CFF Woods 08/01/2019 - 07/31/2020 $774,379
Jason C Woods, PHD MRI Phenotyping of Early BPD and Prediction of Outcomes National Institutes of Health (NIH) R01HL146689 04/01/2020 - 03/31/2021 $774,028
Jason C Woods, PHD A Phase III Trial to Validate HP 129Xe MRI as a Function Polarean Inc. (National Institutes of Health) R44HL123299 04/01/2019 - 03/31/2020 $427,039
Jason C Woods, PHD
Raouf Samy Amin, MD		 UTE MRI to monitor CF lung disease and response to CFTR National Institutes of Health (NIH) R01HL131012 04/01/2020 - 03/31/2021 $703,064
John J Brewington, MD Personalized Model Systems to Predict/Investigate CFTR Drug Response in CF Cystic Fibrosis Foundation CFF_Brewington 08/01/2019 - 07/31/2020 $50,000
John J Brewington, MD Personalized Model Systems to Predict and Investigate CFTR Drug Response in CF National Institutes of Health (NIH) K08HL144825 08/01/2019 - 07/31/2020 $163,620
John Paul Clancy, MD Losartan as anti-inflammatory therapy to augment F508del CFTR recovery University of Miami (Cystic Fibrosis Foundation ) SPC-000389 04/01/2019 - 09/30/2019 $44,836
KYU SHIK MUN Patient-derived Pancreatic Duct-on-a-chip to study CFTR Channel Function Cystic Fibrosis Foundation Mun CFF Fellowship 04/01/2019 - 03/31/2020 $65,450
Laura L Walkup, PHD Early detection of regional BOS in BMT patients using UTE and 129Xe MRI National Institutes of Health (NIH) R00HL138255 04/01/2020 - 03/31/2021 $249,000
Michael Seid, PHD CF Learning Network: Implementation Phase Cystic Fibrosis Foundation SEID19AB0 01/01/2020 - 12/31/2020 $2,918,242
Naga Gowthama Sarma Mylavarapu, PHD Development of Virtual Surgery Technology Platform for Obstructive Sleep Apnea Department of Defense W81XWH1910043 05/01/2019 - 10/31/2020 $261,950
Neil Stewart Rapid, multi-functional MRI for infant lung disease Thrasher Research Fund Thrasher_Stewart 01/01/2020 - 12/31/2020 $13,375
Raouf Samy Amin, MD Upper Airway Structure and Function and Risk for OSA in Children with Down Syndrome Albert Einstein College of Medicine (National Institutes of Health) 311427 05/01/2019 - 04/30/2020 $29,481
Raouf Samy Amin, MD Therapeutic Development Center Award Cystic Fibrosis Foundation CLANCY14Y0 01/01/2019 - 03/31/2020 $24,631
Raouf Samy Amin, MD Additional Research Coordinator (ARC) Award Cystic Fibrosis Foundation CLANCY14Y4 12/01/2018 - 03/31/2021 $7,266
Raouf Samy Amin, MD Pulmonary Vascular Disease in Cystic Fibrosis Cystic Fibrosis Foundation AMIN19A0 01/01/2020 - 12/31/2020 $372,691
Satish K Madala, PHD Therapeutic Benefit of Hsp90 Inhibition in Pulmonary Fib Department of Defense Army W81XWH-17-1-0666 09/30/2019 - 09/29/2020 $583,135
Satish K Madala, PHD IL-31 Regulation of Immunopathology in Pulmonary Fibrosis National Institutes of Health (NIH) R21AG059533 05/01/2019 - 04/30/2021 $206,290
Stacey Ishman, MD-MPH Positive airway pressure for the treatment of obstructive sleep apnea syndrome in children with Down syndrome. Children's Hospital of Philadelphia (National Institutes of Health) 3201930820 09/23/2019 - 08/31/2020 $133,765
Theresa Guilbert, MD-MS ORBEX: Primary Prevention of Asthma and Wheezing in Children University of Arizona (National Institutes of Health) PO 438886 05/01/2019 - 04/30/2020 $143,122
Theresa Guilbert, MD-MS ORBEX: Primary Prevention of Asthma and Wheezing in Children University of Arizona (National Institutes of Health) PO 438886 03/31/2020 - 04/30/2020 $300,000
Theresa Guilbert, MD-MS Vitamin D to prevent Severe Asthma Exacerbations in High-Risk Children-CCC University of Pittsburgh (National Institutes of Health) 0045031 (130888-6) 06/01/2018 - 05/31/2020 $13,330
Vishwaraj Chandrakanth Sontake MOLECULAR MECHANISMS OF PULMONARY FIBROSIS INCYSTIC FIBROSIS Cystic Fibrosis Foundation Sontake CFF 04/01/2019 - 03/31/2020 $65,450
William D Hardie, MD Serum Biomarkers of Pulmonary Fibrosis Induction, Progression and Resolution Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health) 1159-SUB 01/01/2019 - 02/29/2020 $119,250
Zackary Cleveland, PHD Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis. National Institutes of Health (NIH) R01HL143011 01/01/2020 - 12/31/2020 $771,092
Current Year Direct $11,952,381.67

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Assem Ziady, PHD Spark Therapeutics, Inc. $34,321.00
Christopher Towe, MD Boehringer Ingelheim Pharmaceuticals $53,108.00
Gary McPhail, MD Boehringer Ingelheim Pharmaceuticals $166,961.00
Gary McPhail, MD Vertex Pharmaceutical Incorporated $755,276.00
Hemant Sawnani, MD Santhera Pharmaceuticals Inc. $43,350.00
Jason C Woods, PHD University of Cincinnati (Polarean Inc.) $58,894.00
Satish K Madala, PHD Daewoong Pharmaceutical Co., Ltd $74,449.00
Sheharyar Durrani, MD Astrazeneca $163,500.00
Sheharyar Durrani, MD Sanofi Pasteur Biologics, LLC $146,174.00
Total Annual Industry Award Dollars $1,496,033.00